Vagal Stimulation in POTS

Summary

Vagal Stimulation in POTS is a clinical trial^[1].

Key Facts

• Vagal Stimulation in POTS is in the country of United States^[2].
• Vagal Stimulation in POTS's instance of is recorded as clinical trial^[3].
• Vagal Stimulation in POTS's start time is recorded as +2017-09-30T00:00:00Z^[4].
• Vagal Stimulation in POTS's end time is recorded as +2020-07-31T00:00:00Z^[5].
• Vagal Stimulation in POTS's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Vagal Stimulation in POTS's main subject is recorded as tachycardia^[7].
• Vagal Stimulation in POTS's main subject is recorded as postural orthostatic tachycardia syndrome^[8].
• Vagal Stimulation in POTS's number of participants is recorded as {'unit': '1', 'amount': '+16'}^[9].
• Vagal Stimulation in POTS's title is recorded as Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)^[10].
• Vagal Stimulation in POTS's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Vagal Stimulation in POTS's ClinicalTrials.gov ID is recorded as NCT03124355^[12].
• Vagal Stimulation in POTS's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[13].
• Vagal Stimulation in POTS's research intervention is recorded as galantamine^[14].
• Vagal Stimulation in POTS's clinical trial phase is recorded as phase I clinical trial^[15].
• Vagal Stimulation in POTS's principal investigator is recorded as Italo O. Biaggioni^[16].
• Vagal Stimulation in POTS's study type is recorded as interventional study^[17].